Nicorette Inhalaattori (Nicotine)

Nicotine, the active ingredient in Nicorette Inhalaattori, is a nicotine replacement therapy presented as an inhaler for oromucosal use. It is intended to alleviate withdrawal symptoms and reduce the urge to smoke in adult smokers who are trying to quit.

GNH USA supplies Nicorette Inhalaattori as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals and clinics worldwide, with established quality‑assured distribution channels across the EU and other regulated markets. Our team ensures compliance with local regulations and provides technical support for product integration.

Nicotine, delivered via Nicorette Inhalaattori, is used in nicotine replacement therapy to support smoking cessation. - Smoking cessation: helps adult smokers reduce cravings and withdrawal symptoms while they quit tobacco use. - Nicotine dependence: provides a controlled nicotine dose to manage dependence during a quit attempt. - Relapse prevention: can be used as part of a step‑down strategy to maintain abstinence after initial quitting.

Nicotine inhalation may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Cough: transient dry cough after inhalation. - Throat discomfort: irritation or itching in the throat. - Nausea: occasional feeling of queasiness.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or difficulty breathing indicating possible hypersensitivity. - Cardiovascular events: chest pain, palpitations, or hypertension in susceptible individuals.

When using Nicorette Inhalaattori, several precautions should be observed to ensure safe and effective use. - Assess suitability: confirm the patient is an adult smoker seeking to quit and not a minor. - Medical history: evaluate cardiovascular disease, hypertension, or recent myocardial infarction before use. - Pregnancy and lactation: avoid use unless benefits outweigh unknown risks. - Concurrent nicotine products: do not combine with other nicotine replacement therapies to prevent excess exposure. - Adverse reaction monitoring: discontinue if severe irritation, allergic signs, or persistent cardiovascular symptoms occur. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Nicotine inhalation can interact with certain medicines, altering their effects or increasing adverse risk.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): concurrent use may increase hypertensive risk. - Beta‑blockers: nicotine may reduce their effectiveness in controlling heart rate. - Insulin or oral hypoglycemics: nicotine can affect blood glucose control.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): monitor for increased anxiety or insomnia. - Theophylline: nicotine may enhance stimulant effects, watch for tachycardia. - Caffeine: combined use may increase jitteriness; advise moderation.